PL BioScience Unveils Unique Gamma-irradiated Human Platelet Lysate

PL BioScience GmbH, based in Aachen, Germany, has announced the launch of ELAREM™ Ultimate-FD PLUS, a groundbreaking gamma-irradiated Human Platelet Lysate (HPL). This product, manufactured using a patented process, represents a significant step forward in cell culture supplements, particularly for regenerative medicine and cell therapies.

Serving as a safer alternative to Fetal Bovine Serum, this gamma-irradiated HPL aligns with EU regulations and supports the demand for xeno-free, virus-inactivated, ethically sourced supplements. The innovative process reduces safety risks associated with traditional animal-derived products, offering a stable and ethically responsible option for global manufacturers.

ELAREM™ Ultimate-FD PLUS is positioned to meet the stringent requirements of cell manufacturing applications, including potential clinical trial use, by providing a fibrinogen-depleted, anticoagulant-free product in line with GMP standards.